Wen-long Guan
Guangzhou, 510060, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 28 publications
Perioperative Toripalimab Plus Chemotherapy Versus Chemotherapy Alone in Locally Advanced Gastric or Gastroesophageal Junction Cancer: 3-Year Follow-Up of NEOSUMMIT-01 Trial.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: May 05, 2026
Clinical benefit of PD-1 antibody plus chemotherapy in advanced HER2 negative gastric or gastro-oesophageal junction adenocarcinoma according to PD-L1 levels: Post-hoc analysis of RATIONALE-305 and pooled analysis of individual patient-level data.
Journal: Journal of hematology & oncology
Published: April 26, 2026
Vitamin B5 supports anti-PD1 response in HER2-positive gastric cancer and enhances interaction between naïve B cells and T cells.
Journal: Nature communications
Published: September 22, 2025
Dissecting small cell carcinoma of the esophagus ecosystem by single-cell transcriptomic analysis.
Journal: Molecular cancer
Published: December 01, 2024
Percutaneous hepatic artery infusion chemotherapy with oxaliplatin and fluoropyrimidines in treatment-resistant colorectal cancer patients with unresectable liver metastases: a retrospective cohort study.
Journal: HPB : the official journal of the International Hepato Pancreato Biliary Association
Published: June 20, 2024
Clinical outcomes and biomarker exploration of first-line PD-1 inhibitors plus chemotherapy in patients with low PD-L1-expressing of gastric or gastroesophageal junction adenocarcinoma.
Journal: Cancer immunology, immunotherapy : CII
Published: March 18, 2024
The optimal threshold of PD-L1 combined positive score to predict the benefit of PD-1 antibody plus chemotherapy for patients with HER2-negative gastric adenocarcinoma: a meta-analysis.
Journal: Cancer immunology, immunotherapy : CII
Published: February 26, 2024
Author Correction: Perioperative toripalimab and chemotherapy in locally advanced gastric or gastro-esophageal junction cancer: a randomized phase 2 trial.
Journal: Nature medicine
Published: January 08, 2024
A phase II clinical trial of toripalimab in advanced solid tumors with polymerase epsilon/polymerase delta (POLE/POLD1) mutation.
Journal: Signal transduction and targeted therapy
Published: December 14, 2023
The Chinese Society of Clinical Oncology (CSCO): Clinical guidelines for the diagnosis and treatment of gastric cancer, 2023.
Journal: Cancer communications (London, England)
Published: December 08, 2023
The relationship between brain metastasis and HER2 expression status in gastric cancer.
Journal: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico
Published: June 26, 2023
Last Updated: 09/26/2026